| Biotechnology feed | All feeds
(MYL) has entered into an agreement with Takeda Pharmaceutical for two type II diabetes drugs Actoplus Met and Actos, which recorded 2009 sales of $459 million and $3.4 billion, respectively.
Following the agreement, Mylan will be able to launch... Seeking Alpha: Mar 17 2010 7:54PM Matching: fumarate Find similar documents
( MYL ) has entered into an agreement with Takeda Pharmaceutical for two type II diabetes drugs Actoplus Met and Actos, which recorded 2009 sales of $459 million and $3.4 billion, respectively.
Following the agreement, Mylan will be able to... Benzinga.com: Mar 17 2010 5:01PM Matching: fumarate Find similar documents
12 /PRNewswire/ -- Bioniche Pharma, a leading developer and manufacturer of... PR Newswire: Jan 12 2010 4:57PM Matching: fumarate Find similar documents
Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.
All rights reserved. All other trademarks recognized. Copyright 1997-2009 - BioPortfolio Limited.
